ESR 7: Non-invasive NAFLD functional fingerprinting using novel technologies

Project Summary

This project aims at exploring three novel non-invasive technologies: 13C-breath tests (stable-isotope-based liver-targeted substrates), sugar absorption tests (urinary HPLC-based) intestinal permeability and mid-range infra-red fingerprinting of urine and plasma samples, to evaluate Non-Alcoholic Fatty Liver Disease (NAFLD) staging.

Research will include methodologies for developing and applying novel biomarker algorithms for NAFLD diagnosis and staging based on the three novel technologies. The post-holder will have some scope to adapt the project based on their interests.